Abstract
Alginate is a polysaccharide derived from brown seaweed, which has the unique property of being able to form a gel in the presence of certain divalent cations (e.g., calcium, strontium, or barium). Alginate has been of commercial interest in the food industry since the 1930s, when its properties as an emulsifier, thickener, and stabilizer were recognized. Alginate has also long been used for biomedical purposes, particularly in the manufacture of surgical dressings for exuding wounds (1). However, the explosive increase in medical applications for alginate, began with the recognition of its use as a scaffold for the encapsulation and immunoprotection of transplanted cells. The encapsulation of non-autologous islet cells in alginate for the treatment of diabetes is based on the concept that nutrients can diffuse in and insulin out of the alginate construct without triggering an immune response (2–3). Similarly, alginate has been used to immunoprotect recombinant cells delivering tumor-suppressing agents (4–5) and growth hormone (6). Stable cultures in alginate beads have been achieved with a number of cell types including chondrocytes, bone-marrow stromal cells, islets, myoblasts, fibroblasts, Schwann cells, kidney cells, epithelial cells, and hepatocytes. For orthopedic purposes, encapsulated bone-marrow stromal cells and chondrocytes have been proposed for the healing bone and cartilage defects (7–9). As a bulking agent, alginate has gained attention as a space-filling material for treating pediatric urinary reflex (10–12).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Thomas, S. (2000) Alginate dressings in surgery and wound management—Part 1. J. Wound Care 9, 56–60.
Lim, F. and Sun, A. M. (1980) Microencapsulated islets as bioartificial endocrine pancreas. Science 210, 908–910.
Soon-Shiong, P., Heintz, R. E., Merideth, N., Yao, Q. X., Yao, Z., Zheng, T., et al. (1994) Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 343, 950–951.
Cirone, P., Bourgeois, J. M., Austin, R. C., and Chang, P. L. (2002) A novel approach to tumor suppression with microencapsulated recombinant cells. Hum. Gene Ther. 13, 1157–1166.
Joki, T., Machluf, M., Atala, A., Zhu, J., Seyfried, N. T., Dunn, I. F., et al. (2001) Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat. Biotechnol. 19, 35–39.
Chang, P. L. (1997) Microcapsules as bio-organs for somatic gene therapy. Ann. NY Acad. Sci. 831, 461–473.
Shang, Q., Wang, Z., Liu, W., Shi, Y., Cui, L., and Cao, Y. (2001) Tissue-engineered bone repair of sheep cranial defects with autologous bone marrow stromal cells. J. Craniofac. Surg. 12, 586–593.
Fragonas, E., Valente, M., Pozzi-Mucelli, M., Toffanin, R., Rizzo, R., Silvestri, F., et al. (2000) Articular cartilage repair in rabbits by using suspensions of allogenic chondrocytes in alginate. Biomaterials 21, 795–801.
Chang, S. C., Rowley, J. A., Tobias, G., Genes, N. G., Roy, A. K., Mooney, D. J., et al. (2001) Injection molding of chondrocyte/alginate constructs in the shape of facial implants. J, Biomed, Mater, Res, 55, 503–511.
Loebsack, A., Greene, K., Wyatt, S., Culberson, C., Austin, C., Beiler, R., et al. (2001) In vivo characterization of a porous hydrogel material for use as a tissue bulking agent. J. Biomed. Mater. Res. 57, 575–581.
Diamond, D. and Caldamone, A. (1999) Endoscopic correction of vesicoureteral reflux in children using autologous chondrocytes: preliminary results. J. Urol. 162, 1185–1188.
Atala, A., Kim, W., Paige, K. T., Vacanti, C. A., and Retik, A. B. (1994) Endoscopic treatment of vesicoureteral reflux with a chondrocyte-alginate suspension. J. Urol. 152, 641–643; discussion 644.
Dornish, M., Kaplan, D., and Skaugrud, O. (2001) Standards and guidelines for biopolymers in tissue-engineered medical products: ASTM alginate and chitosan standard guides. American Society for Testing and Materials. Ann. NY Acad. Sci. 944, 388–397.
Wong, M., Siegrist, M., Wang, X., and Hunziker, E. (2001) Development of mechanically stable alginate/chondrocyte constructs: effects of guluronic acid content and matrix synthesis. J. Orthop. Res. 19, 493–499.
Draget, K., Myhre, S., Skjak-Break, G., and Ostgaard, K. (1988) Regeneration, cultivation and differentiation of plant protoplasts immobilized in Ca-alginate beads. J. Plant Physiol. 132, 552–556.
Martinsen, A., Skjak-Braek, G., and Smidsrod, O. (1989) Alginate as immobilization material: 1. Correlation between chemical and physical properties of alginate beads. Biotechnol. Bioeng. 33, 79–89.
Kuo, C.K. and Ma, P.X. (2001) Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: part 1. Structure, gelation rate and mechanical properties. Biomaterials 22, 511–521.
Wideroe, H. and Danielsen, S. (2001) Evaluation of the use of Sr2+ in alginate immobilization of cells. Naturwissenschaften 88, 224–228.
Peirone, M., Ross, C. J., Hortelano, G., Brash, J..L., and Chang, P. L. (1998) Encapsulation of various recombinant mammalian cell types in different alginate microcapsules. J. Biomed. Mater. Res. 42, 587–596.
Caterson, E. J., Li, W. J., Nesti, L. J., Albert, T., Danielson, K., and Tuan, R. S. (2002) Polymer/alginate amalgam for cartilage-tissue engineering. Ann. NY Acad. Sci. 961, 134–138.
Lee, K.Y., Alsberg, E., and Mooney, D. J. (2001) Degradable and injectable poly(aldehyde guluronate) hydrogels for bone tissue engineering. J. Biomed. Mater. Res. 56, 228–233.
Halberstadt, C., Austin, C., Rowley, J., Culberson, C., Loebsack, A., Wyatt, S., et al. (2002) A hydrogel material for plastic and reconstructive applications injected into the subcutaneous space of a sheep. Tissue Eng. 8, 309–319.
Hedbom, E., Ettinger, L., and Hauselmann, H. J. (2001) Culture of articular chondrocytes in alginate gel—a means to generate cartilage-like implantable tissue. Osteoarthritis Cartilage 9, S123–130.
Aydelotte, M. B., Greenhill, R. R., and Kuettner, K. E. (1988) Differences between sub-populations of cultured bovine articular chondrocytes. II. Proteoglycan metabolism. Connect. Tissue Res. 18, 223–234.
Aydelotte, M. B. and Kuettner, K. E. (1988) Differences between sub-populations of cultured bovine articular chondrocytes. I. Morphology and cartilage matrix production. Connect. Tissue Res. 18, 205–222.
Grant, G., Morris, E., Rees, D., Smith, P., and Thom, D. (1973) Biological interactions between polysaccharides and divalent cations. FEBS Lett. 32, 195–198.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc.
About this protocol
Cite this protocol
Wong, M. (2004). Alginates in Tissue Engineering. In: Hollander, A.P., Hatton, P.V. (eds) Biopolymer Methods in Tissue Engineering. Methods in Molecular Biology™, vol 238. Humana Press. https://doi.org/10.1385/1-59259-428-X:77
Download citation
DOI: https://doi.org/10.1385/1-59259-428-X:77
Publisher Name: Humana Press
Print ISBN: 978-0-89603-967-4
Online ISBN: 978-1-59259-428-3
eBook Packages: Springer Protocols